Shares of Medical Properties Trust, Inc. (NYSE:MPW) have been given an average rating of “Hold” by the fifteen research firms that are covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $14.00.

A number of equities research analysts have commented on the stock. ValuEngine cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price on the stock in a research note on Wednesday. JMP Securities upgraded shares of Medical Properties Trust from a “market perform” rating to an “outperform” rating and set a $14.00 target price on the stock in a research note on Monday. They noted that the move was a valuation call. BidaskClub upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Finally, Jefferies Group LLC upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and raised their target price for the stock from $13.00 to $15.00 in a research note on Friday, April 7th.

Medical Properties Trust (NYSE MPW) traded up 0.46% during trading on Friday, reaching $13.10. 1,734,267 shares of the company’s stock were exchanged. The company has a market cap of $4.21 billion, a P/E ratio of 15.73 and a beta of 0.89. The stock’s 50-day moving average is $13.03 and its 200-day moving average is $13.02. Medical Properties Trust has a 12-month low of $11.54 and a 12-month high of $15.92.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, May 4th. The real estate investment trust reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. Medical Properties Trust had a net margin of 41.79% and a return on equity of 7.94%. The company had revenue of $156.40 million for the quarter, compared to analysts’ expectations of $156.91 million. During the same quarter last year, the business earned $0.35 EPS. The firm’s revenue was up 15.9% compared to the same quarter last year. Analysts predict that Medical Properties Trust will post $0.87 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, July 14th. Investors of record on Thursday, June 15th were issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.33%. The ex-dividend date was Tuesday, June 13th. Medical Properties Trust’s dividend payout ratio (DPR) is presently 114.29%.

In related news, CFO R Steven Hamner sold 85,000 shares of the firm’s stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.00% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. raised its position in Medical Properties Trust by 6,731.8% in the first quarter. BlackRock Inc. now owns 40,047,534 shares of the real estate investment trust’s stock worth $516,212,000 after buying an additional 39,461,340 shares during the period. Bank of New York Mellon Corp raised its position in Medical Properties Trust by 79.4% in the first quarter. Bank of New York Mellon Corp now owns 12,416,273 shares of the real estate investment trust’s stock worth $160,045,000 after buying an additional 5,493,706 shares during the period. Norges Bank acquired a new position in Medical Properties Trust during the fourth quarter worth $36,638,000. Vanguard Group Inc. raised its position in Medical Properties Trust by 5.3% in the first quarter. Vanguard Group Inc. now owns 54,229,337 shares of the real estate investment trust’s stock worth $699,015,000 after buying an additional 2,705,148 shares during the period. Finally, Alliancebernstein L.P. raised its position in Medical Properties Trust by 97.9% in the first quarter. Alliancebernstein L.P. now owns 2,433,780 shares of the real estate investment trust’s stock worth $31,371,000 after buying an additional 1,204,252 shares during the period. 78.45% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece was first reported by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/07/21/medical-properties-trust-inc-nysempw-given-consensus-recommendation-of-hold-by-brokerages.html.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.